News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,797 Results
Type
Article (31384)
Company Profile (39)
Press Release (201374)
Section
Business (67382)
Career Advice (1806)
Deals (13171)
Drug Delivery (121)
Drug Development (34197)
Employer Resources (191)
FDA (7546)
Job Trends (6720)
News (122662)
Policy (15046)
Tag
Academia (1645)
Alliances (19360)
Alzheimer's disease (776)
Antibody-drug conjugate (ADC) (95)
Approvals (7479)
Artificial intelligence (103)
Bankruptcy (135)
Best Places to Work (5276)
Biosimilars (82)
Breast cancer (102)
Cancer (799)
Cardiovascular disease (94)
Career advice (1513)
CAR-T (79)
Cell therapy (178)
Clinical research (26456)
Collaboration (289)
COVID-19 (2352)
Data (592)
Diabetes (124)
Diagnostics (2490)
Drug pricing (111)
Earnings (25202)
Employer resources (163)
Events (27144)
Executive appointments (168)
FDA (7892)
Funding (225)
Gene therapy (175)
GLP-1 (652)
Government (3535)
Healthcare (7726)
Infectious disease (2422)
Inflammatory bowel disease (83)
Interviews (348)
IPO (5375)
Job creations (1584)
Job search strategy (1232)
Layoffs (466)
Legal (2895)
Lung cancer (138)
Lymphoma (64)
Management (64)
Manufacturing (170)
Medical device (5069)
Medtech (5070)
Mergers & acquisitions (7890)
Metabolic disorders (432)
Neuroscience (1012)
NextGen: Class of 2025 (2848)
Non-profit (2185)
Northern California (657)
Obesity (286)
Opinion (222)
Patents (69)
People (16975)
Phase I (7431)
Phase II (11264)
Phase III (10735)
Pipeline (381)
Podcasts (103)
Policy (106)
Postmarket research (1119)
Preclinical (2730)
Radiopharmaceuticals (152)
Rare diseases (206)
Real estate (2374)
Recruiting (72)
Regulatory (9819)
Research institute (1310)
Resumes & cover letters (282)
Southern California (564)
Startups (1449)
The Weekly (64)
United States (6027)
Vaccines (621)
Weight loss (247)
Date
Today (58)
Last 7 days (255)
Last 30 days (976)
Last 365 days (13939)
2025 (946)
2024 (14078)
2023 (16056)
2022 (22061)
2021 (22809)
2020 (22152)
2019 (19030)
2018 (15316)
2017 (11492)
2016 (10728)
2015 (11601)
2014 (8360)
2013 (6727)
2012 (7271)
2011 (7483)
2010 (6641)
Location
Africa (496)
Asia (14643)
Australia (2464)
California (1502)
Canada (537)
China (135)
Connecticut (89)
Europe (35017)
Florida (217)
Illinois (156)
Indiana (128)
Maryland (402)
Massachusetts (1099)
Minnesota (93)
New Jersey (499)
New York (500)
North Carolina (239)
Northern California (657)
Pennsylvania (320)
South America (640)
Southern California (564)
Texas (191)
Washington State (150)
232,797 Results for "gi supply".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GI Innovation-LaNova Medicines Signs MOU for GI-102 + ADC Pancreatic Cancer Combination Therapy
January 23, 2025
·
2 min read
Press Releases
Natera to Present New Data at the 2025 ASCO GI Symposium
January 21, 2025
·
8 min read
Press Releases
RenovoRx Highlights Promising Pharmacokinetic Data Abstract Presented at ASCO GI 2025
January 27, 2025
·
11 min read
Cancer
BMS, Pfizer Challenge Colorectal Cancer Standard Care With ASCO GI Readouts
Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that could position them as new standards of care in certain subtypes of metastatic colorectal cancer.
January 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentation at ASCO GI 2025
January 9, 2025
·
2 min read
Phase III
Merck’s Keytruda Combo Fails to Extend Survival in Phase III GI Cancer
The unsuccessful Phase III results are the latest to suggest that the blockbuster cancer drug is finally bumping up
against its limits
after racking up around 50 approvals since getting its first FDA nod in September 2014.
January 24, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
January 22, 2025
·
12 min read
Press Releases
Agenus Presents Data at ASCO GI Demonstrating Impact of BOT/BAL in Colorectal Cancer Across Neoadjuvant and Advanced Disease
January 23, 2025
·
9 min read
Press Releases
Oncolytics Biotech® to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium
January 22, 2025
·
10 min read
Press Releases
BPGbio Unveils Research on the Identification of Novel Pancreatic Cancer Patient Subtypes at ASCO GI 2025 Paving the Way for Tailored Treatment
January 22, 2025
·
5 min read
1 of 23,280
Next
